Key result
IV magnesium sulfate shows ~5-fold greater antiarrhythmic effect in low versus normal ionized magnesium patients.
Why the study?
No method previously existed to measure physiologically active free ionized magnesium in blood to guide antiarrhythmic treatment in critically ill patients with arrhythmias.
Does intravenous magnesium sulfate improve antiarrhythmic effects in critically ill patients with cardiac arrhythmias and low serum ionized magnesium compared to those with normal levels?
Does intravenous magnesium sulfate improve antiarrhythmic effects in critically ill patients with cardiac arrhythmias and low serum ionized magnesium compared to those with normal levels?
Intravenous magnesium sulfate is highly effective for the acute management of cardiac arrhythmias in critically ill patients specifically when serum ionized magnesium levels are low.
Answers are grounded in this paper and cite their sources.
May support selective IV magnesium use in low-iMg2+ arrhythmia patients; hypothesis-generating and requires randomized confirmation before practice change.
Magnesium affects cardiac function, although until the recent development of a new ion-selective electrode no method existed for measuring the physiologically active form of magnesium, free ions (iMg2+), in the blood. We investigated the antiarrhythmic effect of magnesium sulfate administered to critically ill patients with cardiac arrhythmias and reduced iMg2+ as determined using the ion-selective electrode. Eight patients with a low iMg2+ level (less than 0.40 mmol/L) were given intravenous magnesium sulfate (group L). Magnesium sulfate was also administered to patients with a normal iMg2+ level (more than 0.40 mmol/L) but who did not respond to conventional antiarrhythmic drugs (group N). Intravenous magnesium sulfate significantly increased the iMg2+ level in patients in group L from 0.35 +/- 0.06 mmol/L (mean +/- SD) to 0.54 +/- 0.09 mmol/L (p < 0.01), and had an antiarrhythmic effect in 7 of the 8 patients (88%). However, in group N patients, intravenous magnesium sulfate had an antiarrhythmic effect in only 1 of the 6 patients (17%) (p < 0.05 vs group L). These results suggest that intravenous magnesium sulfate may be effective in the acute management of cardiac arrhythmias in patients with a low serum iMg2+ level.
No takes yet. Share an insight, caveat, or question.
Kasaoka et al. (1996) studied Cardiac arrhythmias in critically ill patients (n=14). Intravenous magnesium sulfate vs. Patients with normal iMg2+ level (>0.40 mmol/L) unresponsive to conventional antiarrhythmic drugs was evaluated on Antiarrhythmic effect (p=< 0.05). Intravenous magnesium sulfate had an antiarrhythmic effect in 88% of critically ill patients with low ionized magnesium compared to 17% of those with normal levels.
Synapse has enriched 10 related papers. Consider them for comparative context: